Načítá se...
Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
Despite the extensive literature clearly demonstrating the survival benefit for adjuvant chemotherapy in women with operable breast cancer, there are few data confirming this in routine practice. Some studies have suggested that not all women gain to the same extent, with older women showing a small...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2003
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2394463/ https://ncbi.nlm.nih.gov/pubmed/14612889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601366 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|